Key facts
- Longitude Capital Partners IV, LLC filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (LXEO).
- Disclosed ownership: 3.8%.
- Date of event: 30 Sep 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Longitude Capital Partners IV, LLC | 3.8% | 2,765,381 | 0 | 2,765,381 | /s/ Cristiana Blauth Oliveira | Cristiana Blauth Oliveira, Authorized Signatory | |
| Longitude Venture Partners IV, L.P. | 3.8% | 2,765,381 | 0 | 2,765,381 | /s/ Cristiana Blauth Oliveira | Cristiana Blauth Oliveira, Authorized Signatory | |
| Patrick G. Enright | 3.8% | 2,765,381 | 0 | 2,765,381 | /s/ Cristiana Blauth Oliveira | Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright | |
| Juliet Tammenoms Bakker | 3.8% | 2,765,381 | 0 | 2,765,381 | /s/ Cristiana Blauth Oliveira | Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker |
CIK / CUSIP context first